{"title":"Evaluating the Impact of Strategic Alignment on Performance Components of Iranian Pharmaceutical Companies Using Machine Learning Techniques.","authors":"Simin Sadeghi, Mahdi Mohammadzadeh","doi":"10.5812/ijpr-165722","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sustainable performance in the pharmaceutical industry hinges on the strategic alignment of human resources (HR), marketing, and information technology (IT). Prior studies often examined these domains separately; evidence on their joint influence in Iran's pharmaceutical sector remains limited.</p><p><strong>Objectives: </strong>To assess how HR, marketing, and IT strategic alignment relate to profitability, liquidity, and revenue growth using machine-learning methods, and to document model generalization and measurement validity.</p><p><strong>Methods: </strong>This applied, cross-sectional study surveyed 323 managers in Tehran Stock Exchange (TSE)-listed pharmaceutical firms (May to Nov, 2024). A validated questionnaire [CVI/CVR; EFA/ confirmatory factor analysis (CFA); reliability reported] was used only to construct composite indices of HR, marketing, and IT alignment; organizational performance outcomes, profitability, liquidity, and revenue growth (year-over-year) were computed from audited financial statements and then z-standardized. Inputs were min-max scaled to [0, 1]. A feed-forward artificial neural network (ANN; 3-15-1 per outcome; ReLU hidden, linear output) was trained with Levenberg-Marquardt, early stopping, and L2 regularization. Data were split 70/15/15 (train/validation/test) with 5 × 10 repeated cross-validation; bootstrap resampling (B = 1000) produced BCa 95% CIs. Model performance was assessed using mean squared error (MSE), mean absolute error (MAE), root mean square error (RMSE), and R<sup>2</sup>.</p><p><strong>Results: </strong>Aggregate fit was strong (R<sup>2</sup> = 0.91; RMSE = 0.134), with comparable validation/test metrics indicating good generalization. The triadic alignment factor showed the highest association with overall strategic alignment (R<sup>2</sup> = 0.76; P < 0.001). At the subcomponent level, organizational commitment related to profitability (R<sup>2</sup> = 0.59), and aggressive marketing to profitability (R<sup>2</sup> = 0.66). Results are associative, not causal.</p><p><strong>Conclusions: </strong>Machine-learning evidence suggests that coordinated alignment across HR, marketing, and IT is strongly associated with key performance components. The validated instrument, explicit splits, cross-validation, and bootstrap CIs enhance robustness and provide a practical, data-driven framework for managerial action in Iran's pharmaceutical industry.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"24 1","pages":"e165722"},"PeriodicalIF":1.8000,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12915362/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijpr-165722","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Sustainable performance in the pharmaceutical industry hinges on the strategic alignment of human resources (HR), marketing, and information technology (IT). Prior studies often examined these domains separately; evidence on their joint influence in Iran's pharmaceutical sector remains limited.
Objectives: To assess how HR, marketing, and IT strategic alignment relate to profitability, liquidity, and revenue growth using machine-learning methods, and to document model generalization and measurement validity.
Methods: This applied, cross-sectional study surveyed 323 managers in Tehran Stock Exchange (TSE)-listed pharmaceutical firms (May to Nov, 2024). A validated questionnaire [CVI/CVR; EFA/ confirmatory factor analysis (CFA); reliability reported] was used only to construct composite indices of HR, marketing, and IT alignment; organizational performance outcomes, profitability, liquidity, and revenue growth (year-over-year) were computed from audited financial statements and then z-standardized. Inputs were min-max scaled to [0, 1]. A feed-forward artificial neural network (ANN; 3-15-1 per outcome; ReLU hidden, linear output) was trained with Levenberg-Marquardt, early stopping, and L2 regularization. Data were split 70/15/15 (train/validation/test) with 5 × 10 repeated cross-validation; bootstrap resampling (B = 1000) produced BCa 95% CIs. Model performance was assessed using mean squared error (MSE), mean absolute error (MAE), root mean square error (RMSE), and R2.
Results: Aggregate fit was strong (R2 = 0.91; RMSE = 0.134), with comparable validation/test metrics indicating good generalization. The triadic alignment factor showed the highest association with overall strategic alignment (R2 = 0.76; P < 0.001). At the subcomponent level, organizational commitment related to profitability (R2 = 0.59), and aggressive marketing to profitability (R2 = 0.66). Results are associative, not causal.
Conclusions: Machine-learning evidence suggests that coordinated alignment across HR, marketing, and IT is strongly associated with key performance components. The validated instrument, explicit splits, cross-validation, and bootstrap CIs enhance robustness and provide a practical, data-driven framework for managerial action in Iran's pharmaceutical industry.
期刊介绍:
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal include, but are not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy.